Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands	Total	Redemption of Operating Partnership units for stock	Redemption of Operating Partnership units for cash	Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Preferred Operating Partnership	Noncontrolling Interest - Preferred Operating Partnership Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Operating Partnership	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for stock	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for cash	Noncontrolling Interest - Other	Common Stock	Common Stock Redemption of Operating Partnership units for stock	Additional Paid-in Capital	Additional Paid-in Capital Redemption of Operating Partnership units for stock	Additional Paid-in Capital Redemption of Operating Partnership units for cash	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance, beginning of period at Dec. 31, 2020	$ 2,936,124				$ 172,052		$ 215,892			$ 401	$ 1,314		$ 3,000,458			$ (99,093)	$ (354,900)
Balance, beginning of period (in shares) at Dec. 31, 2020											131,357,961
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of options (in shares)											56,722
Issuance of common stock upon the exercise of options	4,254												4,254
Issuance of common stock in connection with share based compensation (in shares)											89,793
Issuance of common stock in connection with share based compensation	3,652												3,652
Restricted stock grants cancelled (in shares)											(2,499)
Issuance of common stock, net of offering costs	273,720										$ 22		273,698
Issuance of common stock, net of offering costs (in shares)											2,185,685
Redemption of Operating Partnership units		$ 0						$ (193)						$ 193
Redemption of Operating Partnership units (in shares)												5,000
Noncontrolling interest in consolidated joint venture	(50)									(50)
Net income (loss)	215,501				3,680		8,828			(5)							202,998
Other comprehensive income	23,013				144		956									21,913
Distributions to Operating Partnership units held by noncontrolling interests	(9,025)				(3,224)		(5,801)
Dividends paid on common stock	(132,540)																(132,540)
Balance, end of period at Mar. 31, 2021	3,314,649				172,652		219,682			346	$ 1,336		3,282,255			(77,180)	(284,442)
Balance, end of period (in shares) at Mar. 31, 2021											133,692,662
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976				259,110		410,053			317	$ 1,339		3,285,948			(42,546)	(128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021	133,922,305										133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)											142,784
Issuance of common stock in connection with share based compensation	$ 4,542												4,542
Restricted stock grants cancelled (in shares)											(779)
Redemption of Operating Partnership units			$ (2,672)	$ (3,375)		$ (3,375)			$ (829)						$ (1,843)
Issuance of common stock in conjunction with acquisitions	40,965										$ 4		40,961
Issuance of common stock in conjunction with acquisitions (in shares)											186,766
Net income (loss)	217,717				4,333		9,805										203,579
Other comprehensive income	51,649				313		2,333									49,003
Distributions to Operating Partnership units held by noncontrolling interests	(14,111)				(4,330)		(9,781)
Dividends paid on common stock	(202,527)																(202,527)
Balance, end of period at Mar. 31, 2022	$ 3,878,164				$ 256,051		$ 411,581			$ 317	$ 1,343		$ 3,329,608			$ 6,457	$ (127,193)
Balance, end of period (in shares) at Mar. 31, 2022	134,251,076										134,251,076